AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

SCYX · NASDAQ · Medical - Pharmaceuticals

SCYNEXIS (SCYX)

Develops antifungal and rare-disease drug candidates under a GSK licensing model.

$5.30

At close+0.13 (+2.51%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions39 holders · as of Jun 30, 2026	51.74%	5.15M shares
Insiders9 holders · as of Jun 30, 2026	3.61%	359.6K shares
Otherremainder	44.65%	4.44M shares

9.95M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (9.95M in the company's Sep 3, 2026 report, 6.29M elsewhere); stakes use the report.

A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Adage Capital Management, L.P.Institution	10.47%	1.04M	13Gfiled Aug 12, 2026 ↗
Great Point Partners LLCInstitution	9.49%	944,292	13Fas of Jun 30, 2026
Squadron Capital Management LLCInstitution	7.61%	756,884	13Fas of Jun 30, 2026
Adage Capital Partners GP, L.L.C.Institution	5.46%	543,478	13Fas of Jun 30, 2026
Propel Bio Management, LLCInstitution	5.46%	543,478	13Fas of Jun 30, 2026
Woodline Partners LPInstitution	3.89%	387,520	13Fas of Jun 30, 2026
Vanguard Capital Management LLCInstitution	2.98%	296,747	13Fas of Jun 30, 2026
Avidity Partners Management LPInstitution	2.62%	260,206	13Fas of Jun 30, 2026
Kingdon Capital Management, L.L.C.Institution	2.49%	247,811	13Fas of Jun 30, 2026
Millennium Management LLCInstitution	1.82%	180,788	13Fas of Jun 30, 2026
Gonzalez David AnguloInsiderdirector, officer: Chief Executive Officer	1.70%	169,641	Form 4filed Apr 2, 2026 ↗
Heights Capital Management, IncInstitution	1.51%	150,551	13Fas of Jun 30, 2026
Dafna Capital Management LLCInstitution	1.37%	135,868	13Fas of Jun 30, 2026
Empery Asset Management, LPInstitution	1.27%	126,451	13Fas of Jun 30, 2026
Acadian Asset Management LLCInstitution	1.17%	116,669	13Fas of Jun 30, 2026
Geode Capital Management, LLCInstitution	0.83%	82,093	13Fas of Jun 30, 2026
Renaissance Technologies LLCInstitution	0.77%	76,525	13Fas of Jun 30, 2026
Scott SukenickInsiderofficer: Chief Legal Officer	0.72%	71,817	Form 4filed Feb 2, 2026 ↗
Vanguard Fiduciary Trust CoInstitution	0.58%	57,970	13Fas of Jun 30, 2026
ivor MacleodInsiderofficer: Chief Financial Officer	0.50%	49,816	Form 4filed Feb 2, 2026 ↗
Adar1 Capital Management, LLCInstitution	0.50%	49,387	13Fas of Jun 30, 2026
BlackRock, Inc.Institution	0.42%	41,522	13Fas of Jun 30, 2026
Velan Capital Investment Management LPInstitution	0.40%	40,000	13Fas of Jun 30, 2026
Northern Trust CorpInstitution	0.22%	22,385	13Fas of Jun 30, 2026
Bridgeway Capital Management, LLCInstitution	0.16%	15,554	13Fas of Jun 30, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Jun 30, 2026

39 holders · 5.15M shares

Holder	Shares	% outstanding	Filed
Great Point Partners LLC	944.3K	9.49%	Aug 14, 2026
Squadron Capital Management LLC	756.9K	7.61%	Aug 14, 2026
Propel Bio Management, LLC	543.5K	5.46%	Aug 13, 2026
Adage Capital Partners GP, L.L.C.	543.5K	5.46%	Aug 14, 2026
Woodline Partners LP	387.5K	3.89%	Aug 14, 2026
Vanguard Capital Management LLC	296.7K	2.98%	Aug 13, 2026
Avidity Partners Management LP	260.2K	2.62%	Aug 14, 2026
Kingdon Capital Management, L.L.C.	247.8K	2.49%	Aug 14, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Adage Capital Management, L.P.	9.99%	1.04M	13G	Aug 12, 2026 ↗
Great Point Partners, LLC	9.99%		13G	Apr 7, 2026 ↗
Avidity Partners Management LP	9.90%		13G	Feb 17, 2026 ↗
Squadron Master Fund LP	9.60%		13G	Apr 8, 2026 ↗
Federated Hermes, Inc.	8.42%		13G	Jan 8, 2026 ↗
CVI Investments, Inc.	6.20%		13G	May 15, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Apr 1, 2026	Gonzalez David Angulodirector, officer: Chief Executive Officer	Purchase · 2 lots	217,390	$1.20	1,465,821

CongressHouse and Senate disclosures

Not reported.